Nutrien Ltd. (TSE:NTR – Free Report) – Stock analysts at Raymond James decreased their Q3 2024 earnings per share (EPS) estimates for shares of Nutrien in a note issued to investors on Monday, November 4th. Raymond James analyst S. Hansen now forecasts that the company will earn $0.65 per share for the quarter, down from their previous forecast of $0.79. The consensus estimate for Nutrien’s current full-year earnings is $5.34 per share. Raymond James also issued estimates for Nutrien’s Q4 2024 earnings at $0.76 EPS, FY2024 earnings at $5.21 EPS and FY2025 earnings at $5.16 EPS.
A number of other brokerages have also recently weighed in on NTR. UBS Group cut Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Thursday, October 10th. Mizuho upgraded Nutrien from a “strong sell” rating to a “hold” rating in a report on Tuesday, July 16th. The Goldman Sachs Group lowered shares of Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 10th. Wells Fargo & Company lowered shares of Nutrien from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 24th. Finally, Hsbc Global Res upgraded shares of Nutrien to a “moderate sell” rating in a report on Friday, August 2nd. Four analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Nutrien has an average rating of “Hold” and a consensus price target of C$64.50.
Nutrien Stock Up 4.5 %
Nutrien stock opened at C$70.56 on Tuesday. The company has a market capitalization of C$34.91 billion, a PE ratio of 31.93, a price-to-earnings-growth ratio of 1.15 and a beta of 0.95. The company has a debt-to-equity ratio of 53.14, a quick ratio of 0.65 and a current ratio of 1.26. Nutrien has a fifty-two week low of C$60.74 and a fifty-two week high of C$83.14. The firm has a 50 day moving average price of C$65.27 and a 200 day moving average price of C$69.46.
Nutrien (TSE:NTR – Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported C$3.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of C$2.87 by C$0.31. Nutrien had a net margin of 3.06% and a return on equity of 3.22%. The business had revenue of C$13.90 billion for the quarter, compared to the consensus estimate of C$14.92 billion.
Insiders Place Their Bets
In other news, Senior Officer Mark Thompson acquired 3,155 shares of the company’s stock in a transaction on Wednesday, September 25th. The shares were bought at an average cost of C$63.79 per share, with a total value of C$201,257.45. In related news, Director Keith Martell purchased 1,250 shares of the company’s stock in a transaction on Thursday, September 19th. The shares were bought at an average cost of C$65.23 per share, for a total transaction of C$81,537.50. Also, Senior Officer Mark Thompson acquired 3,155 shares of the business’s stock in a transaction on Wednesday, September 25th. The shares were bought at an average cost of C$63.79 per share, for a total transaction of C$201,257.45. Insiders bought 12,710 shares of company stock worth $814,824 in the last 90 days. Corporate insiders own 0.03% of the company’s stock.
Nutrien Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Friday, October 18th. Investors of record on Friday, September 27th were paid a $0.54 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $2.16 dividend on an annualized basis and a yield of 3.06%. Nutrien’s dividend payout ratio is currently 132.13%.
About Nutrien
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment distributes crop nutrients, crop protection products, seeds, and merchandise products. The Potash segment provides granular and standard potash products.
Featured Articles
- Five stocks we like better than Nutrien
- Conference Calls and Individual Investors
- Intel: Is Now the Time to Be Brave?Â
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Nutrien Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutrien and related companies with MarketBeat.com's FREE daily email newsletter.